478 related articles for article (PubMed ID: 23571534)
1. Novel bacteriophage lysin with broad lytic activity protects against mixed infection by Streptococcus pyogenes and methicillin-resistant Staphylococcus aureus.
Gilmer DB; Schmitz JE; Euler CW; Fischetti VA
Antimicrob Agents Chemother; 2013 Jun; 57(6):2743-50. PubMed ID: 23571534
[TBL] [Abstract][Full Text] [Related]
2. The Phage Lysin PlySs2 Decolonizes Streptococcus suis from Murine Intranasal Mucosa.
Gilmer DB; Schmitz JE; Thandar M; Euler CW; Fischetti VA
PLoS One; 2017; 12(1):e0169180. PubMed ID: 28046082
[TBL] [Abstract][Full Text] [Related]
3. Synergism between a novel chimeric lysin and oxacillin protects against infection by methicillin-resistant Staphylococcus aureus.
Daniel A; Euler C; Collin M; Chahales P; Gorelick KJ; Fischetti VA
Antimicrob Agents Chemother; 2010 Apr; 54(4):1603-12. PubMed ID: 20086153
[TBL] [Abstract][Full Text] [Related]
4. In vitro antimicrobial activity of ozenoxacin against methicillin-susceptible Staphylococcus aureus, methicillin-resistant S. aureus and Streptococcus pyogenes isolated from clinical cutaneous specimens in Japan.
Kanayama S; Ikeda F; Okamoto K; Nakajima A; Matsumoto T; Ishii R; Amano A; Matsuzaki K; Matsumoto S
J Infect Chemother; 2016 Oct; 22(10):720-3. PubMed ID: 27091753
[TBL] [Abstract][Full Text] [Related]
5. In vitro pharmacokinetic/pharmacodynamic activity of NXL103 versus clindamycin and linezolid against clinical Staphylococcus aureus and Streptococcus pyogenes isolates.
Vidaillac C; Parra-Ruiz J; Winterfield P; Rybak MJ
Int J Antimicrob Agents; 2011 Oct; 38(4):301-6. PubMed ID: 21764263
[TBL] [Abstract][Full Text] [Related]
6. LysGH15, a novel bacteriophage lysin, protects a murine bacteremia model efficiently against lethal methicillin-resistant Staphylococcus aureus infection.
Gu J; Xu W; Lei L; Huang J; Feng X; Sun C; Du C; Zuo J; Li Y; Du T; Li L; Han W
J Clin Microbiol; 2011 Jan; 49(1):111-7. PubMed ID: 21048011
[TBL] [Abstract][Full Text] [Related]
7. Pharmacodynamics of TD-1792, a novel glycopeptide-cephalosporin heterodimer antibiotic used against Gram-positive bacteria, in a neutropenic murine thigh model.
Hegde SS; Okusanya OO; Skinner R; Shaw JP; Obedencio G; Ambrose PG; Blais J; Bhavnani SM
Antimicrob Agents Chemother; 2012 Mar; 56(3):1578-83. PubMed ID: 22155835
[TBL] [Abstract][Full Text] [Related]
8. In Vitro Activities of Tedizolid and Linezolid against Gram-Positive Cocci Associated with Acute Bacterial Skin and Skin Structure Infections and Pneumonia.
Chen KH; Huang YT; Liao CH; Sheng WH; Hsueh PR
Antimicrob Agents Chemother; 2015 Oct; 59(10):6262-5. PubMed ID: 26248355
[TBL] [Abstract][Full Text] [Related]
9. Exploiting Broad-Spectrum Chimeric Lysin to Cooperate with Mupirocin against Staphylococcus aureus-Induced Skin Infections and Delay the Development of Mupirocin Resistance.
Duan XC; Li XX; Li XM; Wang S; Zhang FQ; Qian P
Microbiol Spectr; 2023 Jun; 11(3):e0505022. PubMed ID: 37125939
[TBL] [Abstract][Full Text] [Related]
10. Combination therapy with lysin CF-301 and antibiotic is superior to antibiotic alone for treating methicillin-resistant Staphylococcus aureus-induced murine bacteremia.
Schuch R; Lee HM; Schneider BC; Sauve KL; Law C; Khan BK; Rotolo JA; Horiuchi Y; Couto DE; Raz A; Fischetti VA; Huang DB; Nowinski RC; Wittekind M
J Infect Dis; 2014 May; 209(9):1469-78. PubMed ID: 24286983
[TBL] [Abstract][Full Text] [Related]
11. A novel prophage lysin Ply5218 with extended lytic activity and stability against Streptococcus suis infection.
Zhang H; Zhang C; Wang H; Yan YX; Sun J
FEMS Microbiol Lett; 2016 Sep; 363(18):. PubMed ID: 27481700
[TBL] [Abstract][Full Text] [Related]
12. In vitro activity of dalbavancin and telavancin against staphylococci and streptococci isolated from patients in Canadian hospitals: results of the CANWARD 2007-2009 study.
Karlowsky JA; Adam HJ; Poutanen SM; Hoban DJ; Zhanel GG;
Diagn Microbiol Infect Dis; 2011 Mar; 69(3):342-7. PubMed ID: 21353963
[TBL] [Abstract][Full Text] [Related]
13. Emergence of methicillin-resistant, vancomycin-intermediate Staphylococcus aureus among patients associated with group A Streptococcal pharyngitis infection in southern India.
Gowrishankar S; Thenmozhi R; Balaji K; Pandian SK
Infect Genet Evol; 2013 Mar; 14():383-9. PubMed ID: 23337611
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of a new fluoroquinolone, JNJ-Q2, in murine models of Staphylococcus aureus and Streptococcus pneumoniae skin, respiratory, and systemic infections.
Fernandez J; Hilliard JJ; Morrow BJ; Melton JL; Flamm RK; Barron AM; Lynch AS
Antimicrob Agents Chemother; 2011 Dec; 55(12):5522-8. PubMed ID: 21911568
[TBL] [Abstract][Full Text] [Related]
15. The lytic activity of recombinant phage lysin LysKΔamidase against staphylococcal strains associated with bovine and human infections in the Jiangsu province of China.
Zhou Y; Zhang H; Bao H; Wang X; Wang R
Res Vet Sci; 2017 Apr; 111():113-119. PubMed ID: 28235706
[TBL] [Abstract][Full Text] [Related]
16. A highly active and negatively charged Streptococcus pyogenes lysin with a rare D-alanyl-L-alanine endopeptidase activity protects mice against streptococcal bacteremia.
Lood R; Raz A; Molina H; Euler CW; Fischetti VA
Antimicrob Agents Chemother; 2014 Jun; 58(6):3073-84. PubMed ID: 24637688
[TBL] [Abstract][Full Text] [Related]
17. Novel recombinant endolysin ointment with broad antimicrobial activity against methicillin-resistant Staphylococcus aureus isolated from wounds and burns.
Hamed ZO; Awni AA; Abdulamir AS
Arch Microbiol; 2023 Mar; 205(4):104. PubMed ID: 36869962
[TBL] [Abstract][Full Text] [Related]
18. The Antistaphylococcal Lysin, CF-301, Activates Key Host Factors in Human Blood To Potentiate Methicillin-Resistant
Indiani C; Sauve K; Raz A; Abdelhady W; Xiong YQ; Cassino C; Bayer AS; Schuch R
Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30670427
[TBL] [Abstract][Full Text] [Related]
19. Telavancin: mechanisms of action, in vitro activity, and mechanisms of resistance.
Karlowsky JA; Nichol K; Zhanel GG
Clin Infect Dis; 2015 Sep; 61 Suppl 2():S58-68. PubMed ID: 26316559
[TBL] [Abstract][Full Text] [Related]
20. Clinical characteristics of vancomycin minimum inhibitory concentration of 2 μg/ml methicillin-resistant Staphylococcus aureus strains isolated from patients with bacteremia.
Takesue Y; Nakajima K; Takahashi Y; Ichiki K; Ishihara M; Wada Y; Tsuchida T; Uchino M; Ikeuchi H
J Infect Chemother; 2011 Feb; 17(1):52-7. PubMed ID: 20625789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
